This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romani, L.
Right arrow Articles by Bistoni, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romani, L.
Right arrow Articles by Bistoni, F.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, 10 1997, 611-636, Vol 10, No. 4
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Interleukin-12 in infectious diseases

L Romani, P Puccetti and F Bistoni
Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Italy. iromani@unipg.it

Interleukin-12 (IL-12) is a potent immunoregulatory cytokine that is crucially involved in a wide range of infectious diseases. In several experimental models of bacterial, parasitic, viral, and fungal infection, endogenous IL-12 is required for early control of infection and for generation and perhaps maintenance of acquired protective immunity, directed by T helper type 1 (Th1) cells and mediated by phagocytes. Although the relative roles of IL-12 and gamma interferon in Th1-cell priming may be to a significant extent pathogen dependent, common to most infections is that IL-12 regulates the magnitude of the gamma interferon response at the initiation of infection, thus potentiating natural resistance, favoring Th1-cell development; and inhibiting Th2 responses. Treatment of animals with IL-12, either alone or as a vaccine adjuvant, has been shown to prevent disease by many of the same infectious agents, by stimulating innate resistance or promoting specific reactivity. Although IL-12 may enhance protective memory responses in vaccination or in combination with antimicrobial chemotherapy, it is yet unclear whether exogenous IL-12 can alter established responses in humans. Continued investigation into the possible application of IL-12 therapy to human infections is warranted by the role of the cytokine in inflammation, immunopathology, and autoimmunity.


This article has been cited by other articles:

  • Chandra, J., McCormick, T. S., Imamura, Y., Mukherjee, P. K., Ghannoum, M. A. (2007). Interaction of Candida albicans with Adherent Human Peripheral Blood Mononuclear Cells Increases C. albicans Biofilm Formation and Results in Differential Expression of Pro- and Anti-Inflammatory Cytokines. Infect. Immun. 75: 2612-2620 [Abstract] [Full Text]  
  • Gowen, B. B., Hoopes, J. D., Wong, M.-H., Jung, K.-H., Isakson, K. C., Alexopoulou, L., Flavell, R. A., Sidwell, R. W. (2006). TLR3 Deletion Limits Mortality and Disease Severity due to Phlebovirus Infection. J. Immunol. 177: 6301-6307 [Abstract] [Full Text]  
  • Obi, E, Roy, A, Bates, V, Sandy, C (2006). Bilateral chronic fungal dacryocystitis caused by Candida dubliniensis in a neutropenic patient.. J. Clin. Pathol. 59: 1194-1195 [Abstract] [Full Text]  
  • Gowen, B. B., Smee, D. F., Wong, M.-H., Judge, J. W., Jung, K.-H., Bailey, K. W., Pace, A. M., Rosenberg, B., Sidwell, R. W. (2006). Recombinant eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters.. Antimicrob. Agents Chemother. 50: 2023-2029 [Abstract] [Full Text]  
  • Potvin, D. M., Metzger, D. W., Lee, W. T., Collins, D. N., Ramsingh, A. I. (2003). Exogenous Interleukin-12 Protects against Lethal Infection with Coxsackievirus B4. J. Virol. 77: 8272-8279 [Abstract] [Full Text]  
  • Bruna-Romero, O., Schmieg, J., Del Val, M., Buschle, M., Tsuji, M. (2003). The Dendritic Cell-Specific Chemokine, Dendritic Cell-Derived CC Chemokine 1, Enhances Protective Cell-Mediated Immunity to Murine Malaria. J. Immunol. 170: 3195-3203 [Abstract] [Full Text]  
  • Fieschi, C., Dupuis, S., Catherinot, E., Feinberg, J., Bustamante, J., Breiman, A., Altare, F., Baretto, R., Le Deist, F., Kayal, S., Koch, H., Richter, D., Brezina, M., Aksu, G., Wood, P., Al-Jumaah, S., Raspall, M., da Silva Duarte, A. J., Tuerlinckx, D., Virelizier, J.-L., Fischer, A., Enright, A., Bernhoft, J., Cleary, A. M., Vermylen, C., Rodriguez-Gallego, C., Davies, G., Blutters-Sawatzki, R., Siegrist, C.-A., Ehlayel, M. S., Novelli, V., Haas, W. H., Levy, J., Freihorst, J., Al-Hajjar, S., Nadal, D., de Moraes Vasconcelos, D., Jeppsson, O., Kutukculer, N., Frecerova, K., Caragol, I., Lammas, D., Kumararatne, D. S., Abel, L., Casanova, J.-L. (2003). Low Penetrance, Broad Resistance, and Favorable Outcome of Interleukin 12 Receptor {beta}1 Deficiency: Medical and Immunological Implications. JEM 197: 527-535 [Abstract] [Full Text]  
  • Brodskyn, C., Patricio, J., Oliveira, R., Lobo, L., Arnholdt, A., Mendonca-Previato, L., Barral, A., Barral-Netto, M. (2002). Glycoinositolphospholipids from Trypanosoma cruzi Interfere with Macrophages and Dendritic Cell Responses. Infect. Immun. 70: 3736-3743 [Abstract] [Full Text]  
  • Pasquali, P., Adone, R., Gasbarre, L. C., Pistoia, C., Ciuchini, F. (2002). Effect of Exogenous Interleukin-18 (IL-18) and IL-12 in the Course of Brucella abortus 2308 Infection in Mice. CVI 9: 491-492 [Abstract] [Full Text]  
  • Simmons, C. P., Goncalves, N. S., Ghaem-Maghami, M., Bajaj-Elliott, M., Clare, S., Neves, B., Frankel, G., Dougan, G., MacDonald, T. T. (2002). Impaired Resistance and Enhanced Pathology During Infection with a Noninvasive, Attaching-Effacing Enteric Bacterial Pathogen, Citrobacter rodentium, in Mice Lacking IL-12 or IFN-{gamma}. J. Immunol. 168: 1804-1812 [Abstract] [Full Text]  
  • Tekkanat, K. K., Maassab, H., Berlin, A. A., Lincoln, P. M., Evanoff, H. L., Kaplan, M. H., Lukacs, N. W. (2001). Role of Interleukin-12 and Stat-4 in the Regulation of Airway Inflammation and Hyperreactivity in Respiratory Syncytial Virus Infection. Am. J. Pathol. 159: 631-638 [Abstract] [Full Text]  
  • Zeerleder, S., Hack, C. E., Caliezi, C., Hebeisen, R., Wuillemin, W. A. (2001). Bacillus Calmette-Guerin sepsis: shift of an intended local toward a detrimental systemic cytotoxic immune response. Blood 98: 890-891 [Full Text]  
  • Grohmann, U., Belladonna, M. L., Vacca, C., Bianchi, R., Fallarino, F., Orabona, C., Fioretti, M. C., Puccetti, P. (2001). Positive Regulatory Role of IL-12 in Macrophages and Modulation by IFN-{{gamma}}. J. Immunol. 167: 221-227 [Abstract] [Full Text]  
  • Grohmann, U., Fallarino, F., Silla, S., Bianchi, R., Belladonna, M. L., Vacca, C., Micheletti, A., Fioretti, M. C., Puccetti, P. (2001). CD40 Ligation Ablates the Tolerogenic Potential of Lymphoid Dendritic Cells. J. Immunol. 166: 277-283 [Abstract] [Full Text]  
  • Chiani, P., Bromuro, C., Torosantucci, A. (2000). Defective Induction of Interleukin-12 in Human Monocytes by Germ-Tube Forms of Candida albicans. Infect. Immun. 68: 5628-5634 [Abstract] [Full Text]  
  • Grohmann, U., Bianchi, R., Belladonna, M. L., Silla, S., Fallarino, F., Fioretti, M. C., Puccetti, P. (2000). IFN-{gamma} Inhibits Presentation of a Tumor/Self Peptide by CD8{alpha}- Dendritic Cells Via Potentiation of the CD8{alpha}+ Subset. J. Immunol. 165: 1357-1363 [Abstract] [Full Text]  
  • Xing, Z., Zganiacz, A., Wang, J., Divangahi, M., Nawaz, F. (2000). IL-12-Independent Th1-Type Immune Responses to Respiratory Viral Infection: Requirement of IL-18 for IFN-{gamma} Release in the Lung But Not for the Differentiation of Viral-Reactive Th1-Type Lymphocytes. J. Immunol. 164: 2575-2584 [Abstract] [Full Text]  
  • Pitzurra, L., Cherniak, R., Giammarioli, M., Perito, S., Bistoni, F., Vecchiarelli, A. (2000). Early Induction of Interleukin-12 by Human Monocytes Exposed to Cryptococcus neoformans Mannoproteins. Infect. Immun. 68: 558-563 [Abstract] [Full Text]  
  • Ahuja, S. S., Reddick, R. L., Sato, N., Montalbo, E., Kostecki, V., Zhao, W., Dolan, M. J., Melby, P. C., Ahuja, S. K. (1999). Dendritic Cell (DC)-Based Anti-Infective Strategies: DCs Engineered to Secrete IL-12 Are a Potent Vaccine in a Murine Model of an Intracellular Infection. J. Immunol. 163: 3890-3897 [Abstract] [Full Text]  
  • Van Overtvelt, L., Vanderheyde, N., Verhasselt, V., Ismaili, J., De Vos, L., Goldman, M., Willems, F., Vray, B. (1999). Trypanosoma cruzi Infects Human Dendritic Cells and Prevents Their Maturation: Inhibition of Cytokines, HLA-DR, And Costimulatory Molecules. Infect. Immun. 67: 4033-4040 [Abstract] [Full Text]  
  • Chaussabel, D., Jacobs, F., de Jonge, J., de Veerman, M., Carlier, Y., Thielemans, K., Goldman, M., Vray, B. (1999). CD40 Ligation Prevents Trypanosoma cruzi Infection through Interleukin-12 Upregulation. Infect. Immun. 67: 1929-1934 [Abstract] [Full Text]  
  • Retini, C., Casadevall, A., Pietrella, D., Monari, C., Palazzetti, B., Vecchiarelli, A. (1999). Specific Activated T Cells Regulate IL-12 Production by Human Monocytes Stimulated with Cryptococcus neoformans. J. Immunol. 162: 1618-1623 [Abstract] [Full Text]  
  • Car, B. D., Eng, V. M., Lipman, J. M., Anderson, T. D. (1999). The Toxicology of Interleukin-12: A Review. Toxicol Pathol 27: 58-63 [Abstract]  
  • Ahuja, S. S., Mummidi, S., Malech, H. L., Ahuja, S. K. (1998). Human Dendritic Cell (DC)-Based Anti-Infective Therapy: Engineering DCs to Secrete Functional IFN-{gamma} and IL-12. J. Immunol. 161: 868-876 [Abstract] [Full Text]  
  • Altare, F., Durandy, A., Lammas, D., Emile, J., Lamhamedi, S., Le Deist, F., Drysdale, P., Jouanguy, E., Döffinger, R., Bernaudin, F., Jeppsson, O., Gollob, J. A., Meinl, E., Segal, A. W., Fischer, A., Kumararatne, D., Casanova, J. (1998). Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency. Science 280: 1432-1435 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»